Last reviewed · How we verify
Songling Xuemaikang Capsules
Songling Xuemaikang Capsules is a traditional Chinese medicine formulation that improves blood circulation and removes blood stasis to treat cardiovascular conditions.
Songling Xuemaikang Capsules is a traditional Chinese medicine formulation that improves blood circulation and removes blood stasis to treat cardiovascular conditions. Used for Angina pectoris, Cerebral infarction, Peripheral arterial occlusive disease.
At a glance
| Generic name | Songling Xuemaikang Capsules |
|---|---|
| Sponsor | Xiyuan Hospital of China Academy of Chinese Medical Sciences |
| Drug class | Traditional Chinese medicine herbal formulation |
| Modality | Small molecule |
| Therapeutic area | Cardiovascular |
| Phase | FDA-approved |
Mechanism of action
This herbal capsule combines multiple Chinese medicinal ingredients traditionally used to invigorate blood flow, remove stagnation, and promote microcirculation. The formulation is designed to address cardiovascular and cerebrovascular disorders by improving blood rheology and reducing thrombotic risk through mechanisms consistent with traditional Chinese medicine theory rather than a single molecular target.
Approved indications
- Angina pectoris
- Cerebral infarction
- Peripheral arterial occlusive disease
Common side effects
- Gastrointestinal upset
- Dizziness
- Headache
Key clinical trials
- Songling Xuemaikang Capsules for Cerebral Small Vessel Disease (NA)
- Efficacy of Songling Xuemaikang Capsules on Grade 1 Hypertension: a Randomized Controlled Trial (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: